Mary C. Thomas
Impact in
- Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- RNA and protein synthesis mechanisms
- Epigenetics and DNA Methylation
-
- Cancer-related Molecular Pathways
Papers in
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- Cheng-Ming ChiangShwu-Yuan WuMei-Ling KuoWillem den BestenCharles J. SherrTianyuan ZhouVarsha S. LikhitePaul K. Brindle
- Journals
- Cell Cycle (2 papers)Critical Reviews in Biochemistry and Molecular Biology (1 paper)Journal of Industrial Microbiology & Biotechnology (1 paper)Genetica (1 paper)Genetics (1 paper)
- Partner nations
- United StatesAustraliaDenmark
In The Last Decade
Mary C. Thomas
11 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Molecular Biology 841
- Oncology 179
- Molecular Medicine 32
- Genetics 152
- Cancer Research 73
Countries citing papers authored by Mary C. Thomas
This map shows the geographic impact of Mary C. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary C. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary C. Thomas more than expected).
Fields of papers citing papers by Mary C. Thomas
This network shows the impact of papers produced by Mary C. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary C. Thomas. The network helps show where Mary C. Thomas may publish in the future.
Co-authors
The 24 scholars most cited alongside Mary C. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2013 | 26 | |
| 3 | 2011 | 26 | |
| 4 | 2008 | 58 | |
| 5 | The General Transcription Machinery and General Cofactors Hit paper breakdown → | 2006 | 641 |
| 6 | 2005 | 165 | |
| 7 | 2000 | 35 | |
| 8 | 2000 | 42 | |
| 9 | 1999 | 40 | |
| 10 | 1999 | 10 | |
| 11 | 1998 | 23 |
About Mary C. Thomas
Mary C. Thomas is a scholar working on Molecular Medicine, Endocrinology, Pharmacology, Molecular Biology and Oncology, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Epigenetics and DNA Methylation (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Cancer-related Molecular Pathways (2 papers), Antibiotic Resistance in Bacteria (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Molecular Biology (841 citations), Oncology (179 citations), Molecular Medicine (32 citations), Genetics (152 citations) and Cancer Research (73 citations). Mary C. Thomas has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include Cheng-Ming Chiang, Shwu-Yuan Wu, Mei-Ling Kuo, Willem den Besten, Charles J. Sherr, Tianyuan Zhou, Varsha S. Likhite, Paul K. Brindle, Lawryn H. Kasper and Gerard P. Zambetti. Their work appears in journals such as Cell Cycle, Critical Reviews in Biochemistry and Molecular Biology, Journal of Industrial Microbiology & Biotechnology, Genetica and Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.